Of the 14 CAAs assessed with the Luminex assay, 13 (anti-p53, anti-p16, anti-IMP2, anti-IMP3, anti-SOX2, anti-BIRC5, anti-HIF1-α, anti-HSP60, anti-ENO1, anti-CTAG1B, anti-MUC1, anti-GAL1, and anti-GAL3) showed significantly higher MFI values in the PCa group than in the NC group (Figure 1). The gene discussed is TP53; the disease is posterior cortical atrophy.